PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 33 filers reported holding PROTARA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,380 | -30.1% | 20,587 | 0.0% | 0.00% | – |
| Q2 2023 | $49,203 | -23.6% | 20,587 | 0.0% | 0.00% | – |
| Q1 2023 | $64,437 | +20.1% | 20,587 | +2.8% | 0.00% | – |
| Q4 2022 | $53,651 | -9.1% | 20,019 | 0.0% | 0.00% | – |
| Q3 2022 | $59,000 | 0.0% | 20,019 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -42.2% | 20,019 | 0.0% | 0.00% | – |
| Q1 2022 | $102,000 | -32.0% | 20,019 | -9.9% | 0.00% | – |
| Q4 2021 | $150,000 | -2.6% | 22,215 | -0.3% | 0.00% | – |
| Q3 2021 | $154,000 | -29.0% | 22,279 | 0.0% | 0.00% | – |
| Q2 2021 | $217,000 | -75.7% | 22,279 | -60.7% | 0.00% | – |
| Q1 2021 | $892,000 | -41.7% | 56,676 | -10.3% | 0.00% | – |
| Q4 2020 | $1,530,000 | +146.4% | 63,212 | +71.3% | 0.00% | – |
| Q3 2020 | $621,000 | +28.0% | 36,894 | +123.3% | 0.00% | – |
| Q2 2020 | $485,000 | – | 16,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,674,031 | $13,664,000 | 4.24% |
| Ikarian Capital, LLC | 296,426 | $1,515,000 | 0.20% |
| DLD Asset Management, LP | 229,531 | $1,173,000 | 0.07% |
| Orbimed Advisors | 830,641 | $4,245,000 | 0.07% |
| Boxer Capital, LLC | 209,227 | $1,069,000 | 0.06% |
| Perceptive Advisors | 383,526 | $1,960,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $327,000 | 0.01% |
| Baker Brothers Advisors | 199,671 | $1,020,000 | 0.01% |
| Trexquant Investment LP | 16,313 | $83,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,591 | $141,000 | 0.00% |